Table of Contents Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.0001 par value NEUE New York Stock Exchange (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40537 NEUEHEALTH, INC. (Exact Name of Registra ...

Exhibit 99.1 NEUEHEALTH REPORTS THIRD QUARTER 2024 RESULTS • Delivered strongest financial performance to date in Q3 '24, resulting from continued positive momentum in NeueCare and NeueSolutions business segments • Drove positive Adjusted EBITDA for the third consecutive quarter in 2024; reaffirming Adjusted EBITDA guidance for the full year • Well-positioned to build on success and capitalize on strategic growth opportunities in 2025 and beyond † DORAL, Fla. (November 7, 2024) (BUSINESSWIRE) – NeueHealth, ...

Table of Contents Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.0001 par value NEUE New York Stock Exchange (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40537 NEUEHEALTH, INC. (Exact Name of Registrant as ...

Exhibit 99.1 NEUEHEALTH REPORTS SECOND QUARTER 2024 RESULTS | --- | --- | --- | |------------------------------------|-----------------------|------------| | Key Metrics | As of June \n2024 | 30, \n2023 | | Consumer and Patient Metrics | | | | Value-Based Consumers served | 364,000 | 373,000 | | Enablement Services Lives | 113,000 | 31,000 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | |--------------------------------------------------------|-------|---------------------|----------------|------- ...

Common Stock, $0.0001 par value NEUE New York Stock Exchange For the transition period from to Commission File Number: 001-40537 Registrant's telephone number, including area code: (612) 238-1321 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Item 1. Financial Statements 2 Condensed Consolidated Statements of Changes in Redeemable Preferred Stock and Shareholders' Equity (Deficit) (Unaudited) 5 Condensed Consolidated Statements of Cash Flows (Unaudited) 7 Notes to Condensed Consolidat ...

NEUEHEALTH REPORTS FIRST QUARTER 2024 RESULTS • Drove strong Q1 '24 results, focused on delivering coordinated, consumer-centric care to all populations through strong provider and payor partnerships and proactive consumer engagement • Delivered Revenue of $245.1 million, Net Income from Continuing Operations of $5.7 million, Adjusted EBITDA of $2.5 million in Q1'24, laying a solid foundation for continued profitable growth in 2024 • NeueCare and NeueSolutions segments positioned for continued strong perfor ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Commission file number 001-40537 9250 NW 36th St Suite 420, Doral, FL 33178 (Address of principal executive offices) (Zip Code) Title of each class Trading Symbol(s) Name of each exchange on which registered Indicate by check mark whether the registrant has submitted electronically and posted on its corporate web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.40 ...

"We achieved significant milestones as a company this past year, completing the sale of our California Medicare Advantage business and fully focusing on where we have proven to have the greatest impact - through our care delivery and provider enablement business," said Mike Mikan, President and CEO of NeueHealth. "Our NeueHealth business drove strong results in 2023, delivering $1.2 billion in revenue, up 55% year over year, and serving 461,000 consumers across the country. We have great confidence in this ...

MINNEAPOLIS--(BUSINESS WIRE)--Bright Health Group, Inc. (“Bright Health” or the “Company”) (NYSE: BHG) today announced that it has adopted NeueHealth as its corporate brand name. This reflects the Company’s ongoing focus on its NeueHealth business, which will continue driving long-term sustainable growth of its value-driven, consumer-centric care model, thereby increasing access to high-quality healthcare for all populations across the ACA Marketplace, Medicare, and Medicaid. The Company’s common stock will ...

Table of Contents *Shares have been retroactively adjusted to reflect the decreased number of shares resulting from a 1 for 80 reverse stock split See accompanying Notes to Condensed Consolidated Financial Statements Table of Contents Basis of Presentation: The condensed consolidated financial statements include the accounts of Bright Health Group, Inc. and all subsidiaries and controlled companies. All intercompany balances and transactions are eliminated upon consolidation. The condensed consolidated fina ...